| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cde10605b30794fd676f517ea84dddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d1c64916674986ae6826cb4eec69163 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb5afe99008a848e196c5654dde9436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d2168e9994d0614777405d230927cdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b1383748df65898e27e4432bb97d42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bdcd5542127da550937fa1a60cf042c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c345b886185d4652efa96eb50ee2ec5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a0b6c19dff18394b2cafdb9c7e6cc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44b23261d074b3920cbd2ae8a103d3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e2ee90ed731ad9e95150460b7b9a0dc |
| publicationDate |
2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2097094-A2 |
| titleOfInvention |
Biomarkers for neurological conditions |
| abstract |
Low molecular weight (LMW) peptides have been discovered that are indicative of neurological conditions, such as Alzheimer's Disease (AD), cognitive impairment and brain microhemmorhages. Evaluating patient samples for the presence of such LMW peptides is an effective means of detecting neurological conditions and monitoring the progression of the disease. The LMW peptides are particularly useful in detecting neurological conditions during the early stages without invasive procedures. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8540988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9388242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617337-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47672-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9493562-B2 |
| priorityDate |
2006-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |